Item Type | Name |
Concept
|
Drug Administration Schedule
|
Concept
|
Protein Subunits
|
Concept
|
Staphylococcus aureus
|
Concept
|
Sequence Analysis, DNA
|
Concept
|
2',5'-Oligoadenylate Synthetase
|
Concept
|
Genes, env
|
Concept
|
RNA, Small Nuclear
|
Concept
|
Subcellular Fractions
|
Concept
|
Survival Rate
|
Concept
|
Genes, Regulator
|
Concept
|
RNA, Small Interfering
|
Concept
|
MAP Kinase Signaling System
|
Concept
|
Sequence Analysis, RNA
|
Concept
|
T-Cell Antigen Receptor Specificity
|
Concept
|
Prostaglandin-Endoperoxide Synthases
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Magnetic Resonance Spectroscopy
|
Concept
|
Stereoisomerism
|
Concept
|
Safety
|
Concept
|
Genes, MHC Class II
|
Concept
|
B-Lymphocyte Subsets
|
Concept
|
Spleen Focus-Forming Viruses
|
Concept
|
Cell Survival
|
Concept
|
Receptors, Cell Surface
|
Concept
|
Proto-Oncogenes
|
Concept
|
Genes, Viral
|
Concept
|
Freund's Adjuvant
|
Concept
|
Amino Acid Sequence
|
Concept
|
Stress, Physiological
|
Concept
|
Sheep Diseases
|
Concept
|
Saccharomyces cerevisiae
|
Concept
|
Cohort Studies
|
Concept
|
Specific Pathogen-Free Organisms
|
Concept
|
Streptococcus pneumoniae
|
Concept
|
Injections, Subcutaneous
|
Concept
|
Reference Standards
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Prostate-Specific Antigen
|
Concept
|
Herpes Simplex
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
Concept
|
Protein Synthesis Inhibitors
|
Concept
|
Genes, bcl-2
|
Concept
|
Cell-Free System
|
Concept
|
Saponins
|
Concept
|
Simian Acquired Immunodeficiency Syndrome
|
Concept
|
Molecular Structure
|
Concept
|
Conserved Sequence
|
Concept
|
Immune Sera
|
Concept
|
Adjuvants, Immunologic
|
Concept
|
Retrospective Studies
|
Concept
|
Repetitive Sequences, Nucleic Acid
|
Concept
|
Organ Size
|
Concept
|
Stem Cells
|
Concept
|
Species Specificity
|
Concept
|
Cell Separation
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
Concept
|
Genes, p53
|
Concept
|
Drug Synergism
|
Concept
|
Signal Transduction
|
Concept
|
Nucleic Acid Conformation
|
Concept
|
Nucleic Acid Synthesis Inhibitors
|
Concept
|
Simian Immunodeficiency Virus
|
Concept
|
Merozoite Surface Protein 1
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
Drug Screening Assays, Antitumor
|
Concept
|
Hepatitis B Surface Antigens
|
Concept
|
Reactive Oxygen Species
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Solubility
|
Concept
|
Genes, Reporter
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
Concept
|
Antigens, Surface
|
Concept
|
Survival Analysis
|
Concept
|
Sex Factors
|
Concept
|
Vaccines, Synthetic
|
Concept
|
Self Administration
|
Concept
|
Sheep
|
Concept
|
Sjogren's Syndrome
|
Concept
|
Murine Acquired Immunodeficiency Syndrome
|
Concept
|
Electrophoretic Mobility Shift Assay
|
Concept
|
Binding Sites
|
Concept
|
Saccharomyces cerevisiae Proteins
|
Concept
|
Mice, SCID
|
Concept
|
Mice, Inbred Strains
|
Concept
|
Genes, myc
|
Concept
|
Sphingomyelins
|
Concept
|
Neoplasm Staging
|
Concept
|
Antibody Specificity
|
Concept
|
Sputum
|
Concept
|
Macromolecular Substances
|
Concept
|
Prospective Studies
|
Concept
|
Secretory Rate
|
Concept
|
Immune System
|
Concept
|
Least-Squares Analysis
|
Concept
|
Radiation-Sensitizing Agents
|
Concept
|
Sarcoma, Experimental
|
Concept
|
Immunoglobulin Class Switching
|
Concept
|
Staining and Labeling
|
Concept
|
Spleen
|
Concept
|
Systemic Inflammatory Response Syndrome
|
Concept
|
RNA Splicing
|
Concept
|
Virus Shedding
|
Concept
|
Rats, Sprague-Dawley
|
Concept
|
Swine
|
Concept
|
United States
|
Concept
|
Lupus Erythematosus, Systemic
|
Concept
|
United States Food and Drug Administration
|
Concept
|
Skin Neoplasms
|
Concept
|
Structure-Activity Relationship
|
Concept
|
Immunization, Secondary
|
Concept
|
Carrier State
|
Concept
|
Skin
|
Concept
|
Single-Strand Specific DNA and RNA Endonucleases
|
Concept
|
Streptococcus agalactiae
|
Concept
|
Gene Silencing
|
Concept
|
Base Sequence
|
Concept
|
Follow-Up Studies
|
Concept
|
DNA, Single-Stranded
|
Concept
|
Vaccines, Subunit
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Molecular Sequence Data
|
Concept
|
Lymphocyte Subsets
|
Concept
|
SAIDS Vaccines
|
Concept
|
Heparitin Sulfate
|
Academic Article
|
Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs.
|
Academic Article
|
CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection.
|
Academic Article
|
C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
|
Academic Article
|
Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses.
|
Academic Article
|
From A to Z on CpG.
|
Academic Article
|
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.
|
Academic Article
|
Expression of an endogenous retroviral transcript is associated with murine lupus.
|
Academic Article
|
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
|
Academic Article
|
Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist.
|
Academic Article
|
Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response.
|
Academic Article
|
A role for Toll in autoimmunity.
|
Academic Article
|
Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells.
|
Academic Article
|
Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
|
Academic Article
|
Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma.
|
Academic Article
|
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
|
Academic Article
|
Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12.
|
Academic Article
|
Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration.
|
Academic Article
|
Antitumor mechanisms of oligodeoxynucleotides with CpG and polyG motifs in murine prostate cancer cells: decrease of NF-kappaB and AP-1 binding activities and induction of apoptosis.
|
Academic Article
|
Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.
|
Academic Article
|
CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.
|
Academic Article
|
Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.
|
Academic Article
|
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.
|
Academic Article
|
Exon skipping therapy for Duchenne muscular dystrophy.
|
Academic Article
|
Interleukin-10 functions in vitro and in vivo to inhibit bacterial DNA-induced secretion of interleukin-12.
|
Academic Article
|
Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
|
Academic Article
|
CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
|
Academic Article
|
CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
|
Academic Article
|
CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
|
Academic Article
|
Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.
|
Academic Article
|
CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
|
Academic Article
|
Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.
|
Academic Article
|
Toll-free vaccines?
|
Academic Article
|
CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
|
Academic Article
|
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.
|
Academic Article
|
CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.
|
Academic Article
|
Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.
|
Academic Article
|
The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
|
Academic Article
|
Multifunctional poly(methacrylate) polyplex libraries: A platform for gene delivery inspired by nature.
|
Academic Article
|
B cells express Ly-6C in a Th1 but not Th2 cytokine environment.
|
Academic Article
|
Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
|
Academic Article
|
Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses.
|
Academic Article
|
Antiinfective applications of toll-like receptor 9 agonists.
|
Academic Article
|
The role of CpG dinucleotides in DNA vaccines.
|
Academic Article
|
Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.
|
Academic Article
|
CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel.
|
Academic Article
|
Accumulation of glutathione disulfide mediates NF-kappaB activation during immune stimulation with CpG DNA.
|
Academic Article
|
CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species.
|
Academic Article
|
Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist.
|
Academic Article
|
[Stem cell-induced liver regeneration].
|
Academic Article
|
TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells.
|
Academic Article
|
CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus.
|
Academic Article
|
Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation.
|
Academic Article
|
Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides.
|
Academic Article
|
CpG ODN enhances uptake of bacteria by mouse macrophages.
|
Academic Article
|
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.
|
Academic Article
|
CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha.
|
Academic Article
|
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
|
Academic Article
|
CpG oligonucleotides protect against Venezuelan equine encephalitis virus infection in a route-dependent manner.
|
Academic Article
|
CpG DNA: a novel immunomodulator.
|
Academic Article
|
Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.
|
Academic Article
|
The toll of too much TLR7.
|
Academic Article
|
CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Montanides.
|
Academic Article
|
CpG still rocks! Update on an accidental drug.
|
Academic Article
|
CpG motifs: the active ingredient in bacterial extracts?
|
Academic Article
|
Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaques.
|
Academic Article
|
CpG motifs in bacterial DNA and their immune effects.
|
Academic Article
|
Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner.
|
Academic Article
|
A role for endogenous retroviral sequences in the regulation of lymphocyte activation.
|
Academic Article
|
On the quality control of antisense oligonucleotides.
|
Academic Article
|
Increased expression of novel full-length endogenous mink cell focus-forming-related transcripts in autoimmune mouse strains.
|
Academic Article
|
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
|
Academic Article
|
Identification of an oligodeoxynucleotide sequence motif that specifically inhibits phosphorylation by protein tyrosine kinases.
|
Academic Article
|
CpG-DNA protects against a lethal orthopoxvirus infection in a murine model.
|
Academic Article
|
CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.
|
Academic Article
|
AIMing 2 detect foreign DNA.
|
Academic Article
|
Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.
|
Academic Article
|
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8? T cells induced by melanoma vaccines.
|
Academic Article
|
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.
|
Academic Article
|
CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
|
Academic Article
|
Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes.
|
Academic Article
|
CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma.
|
Academic Article
|
AIMing 2 defend against intracellular pathogens.
|
Academic Article
|
Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells.
|
Academic Article
|
CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway.
|
Academic Article
|
Interruption of a transforming growth factor alpha autocrine loop in Caco-2 cells by antisense oligodeoxynucleotides.
|
Academic Article
|
The role of CpG motifs in innate immunity.
|
Academic Article
|
Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression.
|
Academic Article
|
CpG DNA: trigger of sepsis, mediator of protection, or both?
|
Academic Article
|
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.
|
Academic Article
|
Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.
|
Academic Article
|
CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.
|
Academic Article
|
Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases.
|
Academic Article
|
Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.
|
Academic Article
|
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming.
|
Academic Article
|
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.
|
Academic Article
|
Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers.
|
Academic Article
|
Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgery.
|
Academic Article
|
Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses.
|
Academic Article
|
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms.
|
Academic Article
|
Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.
|
Academic Article
|
Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA.
|
Academic Article
|
Multiple endogenous xenotropic and mink cell focus-forming murine leukemia virus-related transcripts are induced by polyclonal immune activators.
|
Academic Article
|
Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif.
|
Academic Article
|
Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway.
|
Academic Article
|
CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.
|
Academic Article
|
The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.
|
Academic Article
|
Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery.
|
Academic Article
|
Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.
|
Academic Article
|
Antibody repertoire development in fetal and neonatal piglets. IX. Three pathogen-associated molecular patterns act synergistically to allow germfree piglets to respond to type 2 thymus-independent and thymus-dependent antigens.
|
Academic Article
|
Immunology. The toll of cathepsin K deficiency.
|
Academic Article
|
A novel class of immune-stimulatory CpG oligodeoxynucleotides unifies high potency in type I interferon induction with preferred structural properties.
|
Academic Article
|
Cancer and inflammation: promise for biologic therapy.
|
Academic Article
|
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.
|
Academic Article
|
Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria.
|
Academic Article
|
Mechanisms and therapeutic applications of immune stimulatory cpG DNA.
|
Academic Article
|
Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature.
|
Academic Article
|
Mechanism and function of a newly identified CpG DNA motif in human primary B cells.
|
Academic Article
|
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
|
Academic Article
|
Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses.
|
Academic Article
|
Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner.
|
Academic Article
|
A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.
|
Academic Article
|
Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides.
|
Academic Article
|
Rescue of B cells from apoptosis by immune stimulatory CpG DNA.
|
Academic Article
|
Role of endogenous retroviruses in autoimmune diseases.
|
Academic Article
|
CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
|
Academic Article
|
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
|
Academic Article
|
Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA.
|
Academic Article
|
APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
|
Academic Article
|
Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.
|
Academic Article
|
Immune effects and mechanisms of action of CpG motifs.
|
Academic Article
|
Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS.
|
Academic Article
|
CpG DNA is an effective oral adjuvant to protein antigens in mice.
|
Academic Article
|
TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.
|
Academic Article
|
CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
|
Academic Article
|
P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.
|
Academic Article
|
Therapeutic potential of Toll-like receptor 9 activation.
|
Academic Article
|
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens.
|
Academic Article
|
Endogenous secretion of IL-4 maintains growth and Thy-1 expression of a transformed B cell clone.
|
Academic Article
|
Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells.
|
Academic Article
|
Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.
|
Academic Article
|
Heterogeneous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells.
|
Academic Article
|
Immunopharmacology of CpG oligodeoxynucleotides and ribavirin.
|
Academic Article
|
Endogenous retroviruses: potential etiologic agents in autoimmunity.
|
Academic Article
|
Chronic ethanol ingestion by mice increases expression of CD80 and CD86 by activated macrophages.
|
Academic Article
|
Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse.
|
Academic Article
|
Now I know my CpGs.
|
Academic Article
|
Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
|
Academic Article
|
NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS.
|
Academic Article
|
CpG DNA induces cyclooxygenase-2 expression and prostaglandin production.
|
Academic Article
|
Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
|
Academic Article
|
Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients.
|
Academic Article
|
CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans.
|
Academic Article
|
Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment.
|
Academic Article
|
Direct immunologic activities of CpG DNA and implications for gene therapy.
|
Academic Article
|
Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila.
|
Academic Article
|
Subcutaneous, but not intratracheal administration of the TLR9 agonist, CpG DNA transiently reduces parainfluenza-3 virus shedding in newborn lambs.
|
Academic Article
|
CpG motifs in bacterial DNA trigger direct B-cell activation.
|
Academic Article
|
Signal transduction induced by immunostimulatory CpG DNA.
|
Academic Article
|
CpG oligonucleotides as immune adjuvants.
|
Academic Article
|
Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding.
|
Academic Article
|
Oligonucleotides with novel, cationic backbone substituents: aminoethylphosphonates.
|
Academic Article
|
Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers.
|
Academic Article
|
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
|
Academic Article
|
Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors.
|
Academic Article
|
A possible cause of joint destruction in septic arthritis.
|
Academic Article
|
Nonspecific suppression of [3H]thymidine incorporation by "control" oligonucleotides.
|
Academic Article
|
A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.
|
Academic Article
|
Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan.
|
Academic Article
|
Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides.
|
Academic Article
|
Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
|
Academic Article
|
Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.
|
Academic Article
|
Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.
|
Academic Article
|
Modulation of CpG oligodeoxynucleotide-mediated immune stimulation by locked nucleic acid (LNA).
|
Academic Article
|
Enhancing vaccines with immune stimulatory CpG DNA.
|
Academic Article
|
Timing of immunosuppression in the natural history of autoimmune diseases.
|
Academic Article
|
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
|
Academic Article
|
Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
|
Academic Article
|
Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer.
|
Academic Article
|
Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients.
|
Academic Article
|
Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.
|
Academic Article
|
From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA.
|
Academic Article
|
Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
|
Academic Article
|
Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.
|
Academic Article
|
Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma.
|
Academic Article
|
Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
|
Academic Article
|
Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible.
|
Academic Article
|
Bacterial DNA does not increase serum corticosterone concentration or prevent increases induced by other stimuli.
|
Academic Article
|
Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
|
Academic Article
|
Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.
|
Academic Article
|
Type I interferon is the primary regulator of inducible Ly-6C expression on T cells.
|
Academic Article
|
CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
|
Academic Article
|
CpG oligodeoxynucleotide enhances tumor response to radiation.
|
Academic Article
|
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
|
Academic Article
|
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
|
Academic Article
|
Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides.
|
Academic Article
|
Preferential nuclear compartmentalization of endogenous mink cell focus-forming-related retroviral transcripts.
|
Academic Article
|
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.
|
Academic Article
|
CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved.
|
Academic Article
|
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.
|
Academic Article
|
CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.
|
Academic Article
|
Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides.
|
Academic Article
|
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.
|
Academic Article
|
Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells.
|
Academic Article
|
Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy.
|
Academic Article
|
NIH conference. Systemic lupus erythematosus.
|
Academic Article
|
IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.
|
Academic Article
|
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.
|
Academic Article
|
CpG DNA: a pathogenic factor in systemic lupus erythematosus?
|
Academic Article
|
Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.
|
Academic Article
|
Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells.
|
Academic Article
|
Association of murine lupus and thymic full-length endogenous retroviral expression maps to a bone marrow stem cell.
|
Academic Article
|
Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.
|
Academic Article
|
Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB.
|
Academic Article
|
Theoretical and experimental approaches to generalized autoimmunity.
|
Academic Article
|
Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice.
|
Academic Article
|
Retroviruses and autoimmunity.
|
Academic Article
|
Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.
|
Academic Article
|
Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.
|
Academic Article
|
Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
|
Academic Article
|
High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.
|
Academic Article
|
FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga.
|
Academic Article
|
Analysis of thymic endogenous retroviral expression in murine lupus. Genetic and immune studies.
|
Academic Article
|
Increased utilization of polyreactive B cells during periods of generalized immune activation.
|
Academic Article
|
Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep.
|
Academic Article
|
Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?
|
Academic Article
|
Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine.
|
Academic Article
|
Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
|
Academic Article
|
CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide.
|
Academic Article
|
Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
|
Academic Article
|
Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation.
|
Academic Article
|
Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs.
|
Academic Article
|
Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant.
|
Academic Article
|
Advancing Nucleic Acid Therapeutics by Setting Uniform Standards for Experimental Controls.
|
Academic Article
|
Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.
|
Academic Article
|
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.
|
Academic Article
|
Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.
|
Academic Article
|
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients?With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC.
|
Academic Article
|
Xerna? TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers.
|
Academic Article
|
Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver Metastases.
|
Academic Article
|
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.
|